Low-income beneficiaries are also feeling the squeeze. Enrollment in the Low-Income Subsidy (LIS) program dropped from 13.7 ...

Medicare Part D premiums are set to rise sharply as a key federal subsidy is scaled back. The Trump administration plans to ...

Trump administration aims to soften the blow by negotiating with insurers.

The average monthly bid submitted by insurers for 2026 prescription drug plans increased 33% from last year, according to data released by the CMS.

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

The Trump administration is also modifying the premium stabilization program implemented under President Joe Biden.

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...

Medicare Part D changes The Part D Premium Stabilization Demonstration, a one-year program with an optional annual extension for up to two years, may also be going away in 2026.

About 68.5 million Americans are currently enrolled in some type of Medicare plan, with about 90% of enrollees being over age 65, according to the Centers for Medicare & Medicaid Services.

Before the IRA's changes took effect, Medicare patients did not have a cap on the amount of out-of-pocket costs they could expect to pay in a given year. Under the standard Medicare Part D benefit ...